Comparison of Interleukin-11 and rhTPO for Recurrent Colorectal Cancer Patients With Thrombocytopenia
Status:
Unknown status
Trial end date:
2020-02-01
Target enrollment:
Participant gender:
Summary
This randomized controlled clinical phase II study was designed to compare the effect of
rhTPO with rhIL-11 in improving thrombocytopenia in patients with recurrent colorectal cancer
who underwent radiotherapy and with thrombocytopenia.